Delivery Order SPE2DB22D1202-SPE2DB25FUPX9
Award Date
1/16/25
Potential Completion Date
1/17/25
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,664.88 firm fixed-price contract is for the delivery of 30-count capsules of the medication Vraylar, which is used to treat mental health conditions. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.94 delivery order contract is for the supply of Vraylar 1.5 mg capsules, a medication used in the treatment of mental health conditions. The contract has an ultimate completion date of December 30, 2024 and is structured as a firm fixed-price agreement. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $34,509.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $6,061.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used for the treatment of mental health conditions. The contract does not have a set-aside designation, indicating it was awarded through open competition. It is a Delivery Order contract with a Firm Fixed Price pricing type,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,748.66 firm-fixed-price delivery order is for the supply of Vraylar 6 mg capsules, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,441.41 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a medication used to treat mental health conditions. The award is not associated with a set-aside program and has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $17,416.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used for the treatment of mental health conditions. The award is structured as a Firm Fixed Price Delivery Order contract, with an ultimate completion date of August 28, 2024. This contract is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,587.49 fixed-price delivery order is for the provision of Vraylar 3 mg capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,093.77, is for the delivery of Vraylar 1.5 mg capsule 30s, a medication used to treat mental health conditions. The contract is a firm fixed price Delivery Order and has an ultimate completion date of January 28, 2025. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award, valued at $58,251.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 3 mg capsules and has a period of performance through May 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...